Summary of this article
Five major mainboard IPOs, including Wakefit Innovations (D2C home solutions) and Corona Remedies (pharma), open for subscription this week, starting December 8.
ICICI Prudential AMC, Park Medi World, and Nephrocare Health Services will also launch their public issues to tap the primary market.
The week also features the listing of Meesho, Vidya Wires, and Aequs shares on December 10, alongside eight upcoming SME issues.
The primary market is expected to witness strong activity ahead of the year-end. In the upcoming week, investors will see five mainboard issues opening for subscription. On the other hand, shares of three companies will make their D-street debut in the upcoming week as well. Additionally, several SME issues will also open for subscription in the upcoming week.
Here’s a look at some of the key details related to the upcoming public issues, which are set to open in the week starting December 8:
Wakefit Innovations IPO
The initial public offer of Wakefit Innovations Ltd will open for subscription on December 8 and close on December 10. Wakefit Innovations IPO is worth Rs 1,288.89 crore and consists of a fresh issuance of 19.3 million shares amounting to Rs 377.18 crore and an offer for sale of 46.8 million shares aggregating to Rs 911.71 crore.
Wakefit Innovations IPO’s issue price has been fixed at Rs 185 to Rs 195 per share. Retail individual investors can apply for Wakefit Innovations IPO by placing bids for at least 76 shares, which aggregates to an investment of Rs 14,820.
The share allotment status of Wakefit Innovations IPO will be finalised on December 11. Shares of Wakefit Innovations Ltd will be listed on the NSE and BSE. The tentative IPO listing date is December 15.
Wakefit Innovations is a D2C (Direct-to-Consumer) provider of home and sleep solutions. The company’s product portfolio includes mattresses, furniture, and home décor-related products.
Corona Remedies IPO
Corona Remedies IPO will open for subscription on December 8. The subscription window will close on December 10. Corona Remedies IPO is worth Rs 655.37 crore and consists of the share sale of 6.2 million shares.
Corona Remedies IPO’s issue price has been fixed at Rs 1008 to Rs 1062 per share. Retail individual investors can apply for the Corona Remedies IPO by placing bids for at least 14 shares, which aggregates to an investment of Rs 14,868.
The share allotment status of the Corona Remedies IPO will be finalised on December 11. Shares of the Corona Remedies IPO will be listed on the NSE and BSE. The tentative IPO listing date is December 15.
Corona Remedies Ltd is a pharma company which undertakes the development, manufacturing, and marketing of products related to women’s healthcare, cardiology, pain management, and urology.
Nephrocare Health Services IPO
Nephrocare Health Services IPO will open for subscription on December 10 and close on December 12. Nephrocare Health Services’ public issue is worth Rs 871.05 crore and comprises a fresh issuance of 7.7 million shares amounting to Rs 353.4 crore and an offer for sale of 11.3 million shares aggregating to Rs 517.64 crore.
Nephrocare Health Services' IPO price band has been set at Rs 438 to Rs 460 per share. Retail individual investors can apply for the Nephrocare Health Services IPO by placing bids for at least 32 shares, which aggregates to an investment of Rs 14,720.
The share allotment status of Nephrocare Health Services IPO will be finalised on December 15. Shares of Nephrocare Health Services IPO will be listed on the NSE and BSE. The tentative IPO listing date is December 17.
Nephrocare Health Services Ltd is a provider of dialysis care via a wide network of clinics across India. The company also provides services like diagnosis, haemodialysis, home and mobile dialysis, and wellness programs.
Park Medi World IPO
The initial public offer of Park Medi World will open for subscription on December 10 and close on December 12. Park Medi World IPO is valued at Rs 920 crore and comprises a fresh issuance of 47.5 million shares amounting to Rs 770 crore and an offer for sale of 9.3 million shares aggregating to Rs 150 crore.
Park Medi World IPO’s issue price has been fixed at Rs 154 to Rs 162 per share. Retail individual investors can apply for the Park Medi World IPO by placing bids for a minimum of 92 shares, which aggregates to an investment of Rs 14,904.
The share allotment status of the Park Medi World IPO will be finalised on December 15. Shares of Park Medi World IPO will be listed on the NSE and BSE. The tentative IPO listing date is December 17.
Park Medi World operates a private hospital chain in regions of North India. The hospital chain has a total capacity of 3,000 beds.
ICICI Prudential AMC IPO
ICICI Prudential AMC’s IPO will open for subscription on December 12. The AMC’s subscription window is scheduled to close on December 16. ICICI Prudential AMC IPO consists of an offer-for-sale of 49 million shares.
The share allotment status of the ICICI Prudential AMC IPO is likely to be finalised on December 17. Shares of ICICI Prudential AMC IPO will be listed on the NSE and BSE. The tentative IPO listing date is December 19. The price band for the public issue has not been announced.
ICICI Prudential AMC is an asset management company which offers Portfolio Management Services (PMS), Alternative Investment Fund (AIF), and Advisory services.
Meesho, Vidya Wires and Aequs Shares Set To List
Shares of Meesho Ltd, Aequs Ltd and Vidya Wires Ltd are scheduled to list on the NSE and BSE on December 10.
8 SME Issues Set To Open This Week
The initial public offerings of eight SME companies are set to open for subscription in the week starting December 8. K. V. Toys India IPO, Prodocs Solutions IPO and Riddhi Display Equipment IPO will open for subscription on December 8. On December 10, the Unisem Agritech IPO and Shipwaves Online IPO will open for subscription. On December 11, the public issues of Pajson Agro India and HRS Aluglaze will open for subscription. Ashwini Container Movers IPO is scheduled to open on December 12.
